[1] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020; 396, 1204−22.
[2] Guo BJ, Gan H, Xue MS, et al. The changing and predicted trends in chronic obstructive pulmonary disease burden in China, the United States, and India from 1990 to 2030. Int J Chron Obstruct Pulmon Dis, 2024; 19, 695−706. doi:  10.2147/COPD.S448770
[3] Alemayohu MA, Zanolin ME, Cazzoletti L, et al. Burden and risk factors of chronic obstructive pulmonary disease in Sub-Saharan African countries, 1990-2019: a systematic analysis for the Global Burden of disease study 2019. eClinicalMedicine, 2023; 64, 102215. doi:  10.1016/j.eclinm.2023.102215
[4] Rana D, Ghose B. Chronic obstructive pulmonary disease attributable to air pollution in the South Asian countries: global burden of disease study 1990 - 2019. Int J Environ Health Res, 2024, 1-11.
[5] Blanco I, Diego I, Bueno P, et al. Geographic distribution of COPD prevalence in the world displayed by geographic information system maps. Eur Respir J, 2019; 54, 1900610. doi:  10.1183/13993003.00610-2019
[6] Wen H, Xie C, Wang L, et al. Difference in long-term trends in COPD mortality between China and the U. S. , 1992-2017: an age-period-cohort analysis. Int J Environ Res Public Health, 2019; 16, 1529.
[7] Mei F, Dalmartello M, Bonifazi M, et al. Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: an update to 2019. Respirology, 2022; 27, 941−50. doi:  10.1111/resp.14328
[8] García Castillo E, Alonso Pérez T, Peláez A, et al. Trends of COPD in Spain: changes between cross sectional surveys 1997, 2007 and 2017. Arch Bronconeumol, 2023; 59, 142−51. doi:  10.1016/j.arbres.2022.11.014
[9] Hernández-Garduño E, Ocaña-Servín HL. Temporal trends in chronic obstructive pulmonary disease mortality in Mexico, 1999-2014. Int J Tuberc Lung Dis, 2017; 21, 357−62. doi:  10.5588/ijtld.16.0571
[10] Bhatta L, Leivseth L, Mai XM, et al. Prevalence and trend of COPD from 1995-1997 to 2006-2008: the HUNT study, Norway. Respir Med, 2018; 138, 50−6. doi:  10.1016/j.rmed.2018.03.020
[11] Mathioudakis AG, Vanfleteren LEGW, Lahousse L, et al. Current developments and future directions in COPD. Eur Respir Rev, 2020; 29, 200289. doi:  10.1183/16000617.0289-2020
[12] Sapbamrer P, Assavanopakun P, Panumasvivat J. Decadal trends in ambient air pollutants and their association with COPD and lung cancer in upper northern Thailand: 2013-2022. Toxics, 2024; 12, 321. doi:  10.3390/toxics12050321
[13] Zou JH, Sun T, Song XH, et al. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. Respir Res, 2022; 23, 90. doi:  10.1186/s12931-022-02011-y
[14] Al Wachami N, Guennouni M, Iderdar Y, et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMC Public Health, 2024; 24, 297. doi:  10.1186/s12889-024-17686-9
[15] Wang ZH, Li Y, Lin JF, et al. Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort. BMJ Open Respir Res, 2023; 10, e001550. doi:  10.1136/bmjresp-2022-001550
[16] Zhang XL, Lei ZY, Wu Y, et al. Prevalence and risk factors for COPD in an urbanizing rural area in western China: a cross-sectional study. Int J Chron Obstruct Pulmon Dis, 2023; 18, 459−68. doi:  10.2147/COPD.S400213
[17] Adeloye D, Song PG, Zhu YJ, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med, 2022; 10, 447−58. doi:  10.1016/S2213-2600(21)00511-7
[18] Wang N, Cong S, Fan J, et al. Geographical disparity and associated factors of COPD prevalence in China: a spatial analysis of national cross-sectional study. Int J Chron Obstruct Pulmon Dis, 2020; 15, 367−77. doi:  10.2147/COPD.S234042
[19] Lee SY, Nyunt MSZ, Gao Q, et al. Co-occurrence of physical frailty and COPD and association with disability and mortality: Singapore longitudinal ageing study. Chest, 2022; 161, 1225−38. doi:  10.1016/j.chest.2021.12.633
[20] Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2019 (GBD 2019) human resources for health 1990-2019. Seattle: Institute for Health Metrics and Evaluation (IHME), 2022.
[21] GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry, 2022; 9, 137−50. doi:  10.1016/S2215-0366(21)00395-3
[22] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020; 396, 1223−49. doi:  10.1016/S0140-6736(20)30752-2
[23] Jamrozik E, Musk AW. Respiratory health issues in the Asia-Pacific region: an overview. Respirology, 2011; 16, 3−12.
[24] Cheng SL, Lin CH. COPD guidelines in the Asia-Pacific regions: similarities and differences. Diagnostics, 2021; 11, 1153. doi:  10.3390/diagnostics11071153
[25] World Health Organization. International Classification of Diseases (ICD). https://www.who.int/standards/classifications/classification-of-diseases. [2024-08-27].
[26] Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology, 2004; 9, 458−65. doi:  10.1111/j.1440-1843.2004.00637.x
[27] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000; 19, 335−51. doi:  10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
[28] Joinpoint. Joinpoint help system. https://surveillance.cancer.gov/help/joinpoint/. [2022-02-07].
[29] Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual per cent change in trend analysis. Stat Med, 2009; 28, 3670−82. doi:  10.1002/sim.3733
[30] Wu J, Yang SG, Xu KJ, et al. Patterns and trends of liver cancer incidence rates in eastern and southeastern Asian countries (1983-2007) and predictions to 2030. Gastroenterology, 2018; 154, 1719-28. e5.
[31] Møller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev, 2002; 11 Suppl 1, S1-96.
[32] Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 2008; 24, 349−56. doi:  10.1097/MOG.0b013e3282fbf9b3
[33] Nations United. World population prospects 2019. New York: United Nations, Department of Economics and Social Affairs, Population Division, 2019.
[34] Dacha S, Chaiwong W, Tajarernmuang P. Association of cardiovascular disease with COPD: cardiac function and structure evaluation. J Bras Pneumol, 2022; 48, e20220388.
[35] Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet, 2022; 399, 2227−42. doi:  10.1016/S0140-6736(22)00470-6
[36] Shaddick G, Thomas ML, Mudu P, et al. Half the world’s population are exposed to increasing air pollution. npj Clim Atmos Sci, 2020; 3, 23. doi:  10.1038/s41612-020-0124-2
[37] Sicard P, Agathokleous E, Anenberg SC, et al. Trends in urban air pollution over the last two decades: a global perspective. Sci Total Environ, 2023; 858, 160064. doi:  10.1016/j.scitotenv.2022.160064
[38] Lee KK, Bing R, Kiang J, et al. Adverse health effects associated with household air pollution: a systematic review, meta-analysis, and burden estimation study. Lancet Glob Health, 2020; 8, e1427−34. doi:  10.1016/S2214-109X(20)30343-0
[39] China Association on Tobacco Control for Health. http://www.catcprc.org.cn/. [2024-08-24]. (In Chinese)
[40] Furlow B. Tobacco control, lung cancer, and tuberculosis in Singapore. Lancet Respir Med, 2018; 6, 741−2. doi:  10.1016/S2213-2600(18)30379-5
[41] Satpathy N, Jena PK, Epari V. Gender dimensions of youth vulnerability toward access to cigarettes in South-East Asia: evidence from global youth tobacco survey. Front Public Health, 2022; 10, 976440. doi:  10.3389/fpubh.2022.976440
[42] Kim S, Byun G, Jo G, et al. Gender and tobacco epidemic in South Korea: implications from age-period-cohort analysis and the DPSEEA framework. BMJ Open, 2022; 12, e058903. doi:  10.1136/bmjopen-2021-058903
[43] Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J, 2019; 53, 1801193.
[44] World Health Organization. Smoking is the leading cause of chronic obstructive pulmonary disease. https://www.who.int/news/item/15-11-2023-smoking-is-the-leading-cause-of-chronic-obstructive-pulmonary-disease. [2024-11-24].
[45] Chan KH, Xiao D, Zhou MG, et al. Tobacco control in China. Lancet Public Health, 2023; 8, e1006−15. doi:  10.1016/S2468-2667(23)00242-6
[46] Huang J, Pan XC, Guo XB, et al. Health impact of China’s air pollution prevention and control action plan: an analysis of national air quality monitoring and mortality data. Lancet Planet Health, 2018; 2, e313−23. doi:  10.1016/S2542-5196(18)30141-4
[47] Topic Group of Party School of the Central Committee of CPC. Tobacco control: international experience and China’s strategy. Central Party School Publishing House. 2013. (In Chinese)
[48] The World Bank. World Bank country and lending groups—World Bank data. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank country-and-lending-groups. [2024-11-24].